InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by LUCI DAVID P, Chief Executive Officer. Officer active across 1 companies, notably Acurx Pharmaceuticals, Inc.. In total, 2 disclosures have been logged. Total volume traded: €44k. The latest transaction was filed on 19 November 2021 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations2 total
€21,9565,200 shares@ €4.2222100.0% of flow
Common Stock
SEC:0001104659-21-142471·
Ideal exit: 16 Aug 2022 (T+270)
€21,9565,200 shares@ €4.22220.38% mcap50.0% of flow
Common Stock
SEC:0001104659-21-142471:0·
Ideal exit: 16 Aug 2022 (T+270)
2 of 2 declarations
About LUCI DAVID P
David P. Luci is President and CEO of Acurx Pharmaceuticals, Inc. He leads the company in its efforts to research and develop new drugs. His leadership is crucial for Acurx's strategy and growth.
